NOTES RECEIVABLE (Details Narrative) - USD ($)				1 Months Ended					9 Months Ended	12 Months Ended
	May 03, 2021	Feb. 10, 2021	Nov. 09, 2020	Sep. 16, 2021	May 26, 2021	Sep. 16, 2020	Jul. 31, 2020	Nov. 12, 2019	Sep. 30, 2021	Dec. 31, 2020	Nov. 01, 2019
Convertible promissory note			$ 200,000
Outstanding shares of common stock					20,000,000
Principal amount	$ 200,000		$ 300,000	$ 200,000
Conversion price									$ 1.32	$ 1.32
Interest Rate									18.00%	1.00%
Coeptis Pharmaceuticals, Inc. [Member]
Outstanding shares of common stock					20,000,000
Request for conversion description					(a “Qualified Financing”). The May 2021 Loan shall automatically convert at the initial closing of and on the same terms and conditions of the Qualified Financing into a total number of Qualified Financing Securities, rounded down to the nearest whole share, obtained by dividing the May 2021 Loan by the lesser of (i) 80% of the price per share paid for the Qualified Financing Securities by investors in the Qualified Financing and (ii) $20 million by the number of outstanding shares of common stock of BRC immediately prior to such conversion (assuming conversion of all securities convertible into common stock and exercise of all outstanding options and warrants of BRC, but excluding (a) the shares of equity securities of BRC issued or issuable upon the conversion of the Notes, (b) all shares of the common stock reserved and available for future grant under any equity incentive or similar plan of BRC and (c) any equity incentive or similar plan to be created or increased in connection with the Qualified Financing).
Convertible debt					$ 4,000,000						$ 200,000
Principal amount		$ 200
Conversion price								$ 2.60
Maturity date								Jun. 15, 2020
The Sera Labs, Inc. [Member]
Convertible promissory note							$ 500,000
Principal amount						$ 550,000
Maturity date							Dec. 31, 2020
Interest Rate								9.00%
Interest upon principal amount						$ 500,000
Promissory note, description						The principal amount to $0.55 million with interest on $0.5 million of the principal amount accruing from and after July 31, 2020 and on $0.05 million of the principal amount from and after September 16, 2020.